Evidence map›Paper›PMID 40277221›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025

Full-Length Cryptochrome 1 in the Outer Segments of the Retinal Blue Cone Photoreceptors in Humans and Great Apes Suggests a Role Beyond Transcriptional Repression.

Rabea Bartölke, Christine Nießner, Katja Reinhard, Uwe Wolfrum, Sonja Meimann, Petra Bolte, Regina Feederle, Henrik Mouritsen, Karin Dedek, Leo Peichl and 1 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rabea BartölkeInstitute for Biology and Environmental Sciences (IBU), Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.ORCID https://orcid.org/0000-0003-2531-747X
Christine NießnerMax Planck Institute for Brain Research, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0001-7985-4102
Katja ReinhardRetinal Circuits and Optogenetics, Centre for Integrative Neuroscience and Bernstein Center for Computational Neuroscience, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0002-8719-7445
Uwe WolfrumInstitute of Molecular Physiology, Johannes Gutenberg University, Mainz, Germany.ORCID https://orcid.org/0000-0002-4756-5872
Sonja MeimannInstitute of Cellular and Molecular Anatomy, Dr. Senckenberg Anatomy, Goethe University, Frankfurt am Main, Germany.
Petra BolteInstitute for Biology and Environmental Sciences (IBU), Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.ORCID https://orcid.org/0000-0002-5514-6205
Regina FeederleMonoclonal Antibody Core Facility, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.ORCID https://orcid.org/0000-0002-3981-367X
Henrik MouritsenInstitute for Biology and Environmental Sciences (IBU), Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.ORCID https://orcid.org/0000-0001-7082-4839
Karin DedekInstitute for Biology and Environmental Sciences (IBU), Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.ORCID https://orcid.org/0000-0003-1490-0141
Leo PeichlMax Planck Institute for Brain Research, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0002-8141-0911
Michael WinklhoferInstitute for Biology and Environmental Sciences (IBU), Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.ORCID https://orcid.org/0000-0003-1352-9723

Funding

Deutsche Forschungsgemeinschaft (DFG) 395940726EC | European Research Council (ERC) 810002Human Frontier Science Program (HFSP) RGP13/2013Pro Retina-Stiftung (Pro Retina Foundation)
6 · The paper itself

Abstract

Mammalian cryptochrome 1 (CRY1) is a central player in the circadian transcription-translation feedback loop, crucial for maintaining a roughly 24-h rhythm. CRY1 was suggested to also function as a blue-light photoreceptor in humans and has been found to be expressed at the mRNA level in various cell types of the inner retina. However, attempts to detect CRY1 at the protein level in the human retina have remained unsuccessful so far. Using various C-terminal specific antibodies recognizing full-length CRY1 protein, we consistently detected selective labeling in the outer segments of short wavelength-sensitive (SWS1, "blue") cone photoreceptor cells across human, bonobo, and gorilla retinae. No other retinal cell types were stained, which is in contrast to what would be expected of a ubiquitous clock protein. Subcellular fractionation experiments in transfected HEK cells using a C-terminal specific antibody located full-length CRY1 in the cytosol and membrane fractions. Our findings indicate that human CRY1 has several different functions including at least one nonclock function. Our results also raise the likely possibility that several different versions of CRY1 exist in humans. We suggest that truncation of the C-terminal tail, maybe to different degrees, may affect the localization and function of human CRY1.

Indexed as

CryptochromesRetinal Cone Photoreceptor CellsRetinal Photoreceptor Cell Outer SegmentAnimalsHEK293 CellsHumansRetinaTranscription, GeneticCRY1 protein, humanCryptochromesblue‐light receptorscircadian rhythmscryptochromesC‐terminal tailmolecular clockphotoreceptorsphototransductionretinaSWS1 cones

Identifiers

PMID40277221
PMCPMC12023722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.